rs78516934
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_012433.4(SF3B1):c.3867C>T(p.Asn1289Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00864 in 1,534,372 control chromosomes in the GnomAD database, including 69 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0062 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0089 ( 63 hom. )
Consequence
SF3B1
NM_012433.4 synonymous
NM_012433.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.888
Publications
5 publications found
Genes affected
SF3B1 (HGNC:10768): (splicing factor 3b subunit 1) This gene encodes subunit 1 of the splicing factor 3b protein complex. Splicing factor 3b, together with splicing factor 3a and a 12S RNA unit, forms the U2 small nuclear ribonucleoproteins complex (U2 snRNP). The splicing factor 3b/3a complex binds pre-mRNA upstream of the intron's branch site in a sequence independent manner and may anchor the U2 snRNP to the pre-mRNA. Splicing factor 3b is also a component of the minor U12-type spliceosome. The carboxy-terminal two-thirds of subunit 1 have 22 non-identical, tandem HEAT repeats that form rod-like, helical structures. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 2-197392351-G-A is Benign according to our data. Variant chr2-197392351-G-A is described in ClinVar as [Benign]. Clinvar id is 790342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.888 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00625 (951/152208) while in subpopulation NFE AF = 0.00991 (674/68012). AF 95% confidence interval is 0.00929. There are 6 homozygotes in GnomAd4. There are 447 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 951 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SF3B1 | NM_012433.4 | c.3867C>T | p.Asn1289Asn | synonymous_variant | Exon 25 of 25 | ENST00000335508.11 | NP_036565.2 | |
SF3B1 | XM_047443838.1 | c.3429C>T | p.Asn1143Asn | synonymous_variant | Exon 22 of 22 | XP_047299794.1 | ||
SF3B1 | XM_047443839.1 | c.3429C>T | p.Asn1143Asn | synonymous_variant | Exon 22 of 22 | XP_047299795.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00625 AC: 951AN: 152090Hom.: 6 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
951
AN:
152090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00599 AC: 1498AN: 250280 AF XY: 0.00593 show subpopulations
GnomAD2 exomes
AF:
AC:
1498
AN:
250280
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00890 AC: 12301AN: 1382164Hom.: 63 Cov.: 24 AF XY: 0.00856 AC XY: 5925AN XY: 692322 show subpopulations
GnomAD4 exome
AF:
AC:
12301
AN:
1382164
Hom.:
Cov.:
24
AF XY:
AC XY:
5925
AN XY:
692322
show subpopulations
African (AFR)
AF:
AC:
36
AN:
31756
American (AMR)
AF:
AC:
44
AN:
44426
Ashkenazi Jewish (ASJ)
AF:
AC:
176
AN:
25670
East Asian (EAS)
AF:
AC:
4
AN:
39340
South Asian (SAS)
AF:
AC:
28
AN:
84408
European-Finnish (FIN)
AF:
AC:
429
AN:
53372
Middle Eastern (MID)
AF:
AC:
2
AN:
5628
European-Non Finnish (NFE)
AF:
AC:
11183
AN:
1039850
Other (OTH)
AF:
AC:
399
AN:
57714
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
492
984
1477
1969
2461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00625 AC: 951AN: 152208Hom.: 6 Cov.: 32 AF XY: 0.00601 AC XY: 447AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
951
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
447
AN XY:
74410
show subpopulations
African (AFR)
AF:
AC:
56
AN:
41532
American (AMR)
AF:
AC:
20
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
28
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
104
AN:
10576
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
674
AN:
68012
Other (OTH)
AF:
AC:
7
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
44
87
131
174
218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.